Anesthetic Agents

PreclinicalSmall molecule

Anesthetic Agents is one of 27 small molecule programs targeting Subarachnoid Hemorrhage. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Subarachnoid HemorrhageActive, not recruiting

Subarachnoid HemorrhagePreclinical

Active, not recruiting

Competition

Competitive Landscape

34 competitors in Subarachnoid Hemorrhage

#DrugCompanyPhaseTrials

Cardene

Sun Pharmaceutical Industries, Inc.

Approved

1 2

Keppra

UCB

Approved

1 3

Olumiant

Pletal

2 5

Xylocaine

MMEDRx USA, Inc.

Approved

2 6

Neurontin

VViatris Specialty LLC

Approved

1 7

Duragesic

Marcaine

Angiomax

BBaxter Healthcare Corporation

Approved

—10

Heparin Sodium

BBaxter Healthcare Corporation

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Recruiting

Anesthesia

NCT07410702

Clinical

Trials by Indication[1]

Major Depression1 trial

N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression

Terminated·MMassachusetts General Hospital·Phase 4·NCT01260649·17 enrolled

Anesthesia1 trial

Correlating EEG Dynamics With Consciousness Alteration Under Anesthesia

Recruiting·HHuazhong University of Science and Technology··NCT07410702·250 enrolled

Subarachnoid Hemorrhage1 trial

Enzymatic Evaluation of General Anesthetic Induced Neurotoxicity in Patients With Aneurysmal Subarachnoid Hemorrhage

Completed·MMukilan Balu··NCT03213392·32 enrolled

Pediatric Patients1 trial

The Effect Of Positive End-Expiratory Pressure on Optic Nerve Sheath Diameter In Pediatric Patients Undergoing Craniotomy in Supine Position

Completed·—·N/A·NCT07370779·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Anesthetic Agents. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Anesthetic Agents compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Anesthetic Agents. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Massachusetts General Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMassachusetts General Hospital

Anesthetic Agents

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Trials by Indication[1]

Major Depression1 trial

Anesthesia1 trial

Subarachnoid Hemorrhage1 trial

Pediatric Patients1 trial

References

Drug Info

Quick Facts

Related News